Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2007, Vol. 109, No. 7, pp. 3084-3087.
Prepublished online as a Blood First Edition Paper on November 30, 2006November 21, 2006; DOI 10.1182/blood-2006-06-032599.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-06-032599v1
blood-2006-06-032599v2
109/7/3084    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobsen, L. C
Right arrow Articles by Borregaard, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobsen, L. C
Right arrow Articles by Borregaard, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 29, 2006
Accepted November 19, 2006

Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils

Lars C Jacobsen*, Kim Theilgaard-Moench, Erik I Christensen, and Niels Borregaard

The Granulocyte Research Laboratory, Department of Hematology, University Hospital, Copenhagen, Denmark
Department of Anatomy, University of Aarhus, Aarhus, Denmark

* Corresponding author; email: borregaard{at}rh.dk.

Arginase 1 (ARG1) metabolizes arginine- , thus reducing the availability of arginine as a substrate for nitric oxide synthase (NOS). The decreased production of nitric oxide (NO) by NOS and the production of ornithine by ARG1 affect immune responses and tissue regeneration at sites of infection, respectively. We here demonstrate that ARG1 is synthesized in myelocytes/metamyelocytes and is stored in gelatinase granules. In accordance with this, activated neutrophils coreleased ARG1 and gelatinase to the extracellular environment upon stimulation with phorbol-12-myristate 13-acetate (PMA), formyl-methionyl-leucyl-phenylalanine (fMLP), or tumor necrosis factor alpha (TNF-{alpha}). Overall, these findings define ARG1 as a genuine gelatinase granule protein and support a model where activated neutrophils release ARG1 at sites of infection in order modulate immune responses and promote tissue regeneration.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020